[CLINICAL CONTRIBUTION TO THE STUDY OF A NEW SYNTHETIC ANTICHOLESTEREMIC AGENT: BETA-BENZALBUTYRRAMIDE].
D000577:Amides; D000924:Anticholesteremic Agents; D001168:Arthritis; D001172:Arthritis, Rheumatoid; D001249:Asthma; D002087:Butyrates; D002769:Cholelithiasis; D004796:Clinical Enzyme Tests; D003327:Coronary Disease; D005234:Fatty Liver; D006327:Heart Block; D006801:Humans; D006937:Hypercholesterolemia; D006973:Hypertension; D008055:Lipids / Q000097:blood*; D008074:Lipoproteins; D008111:Liver Function Tests; D009765:Obesity; D010600:Pharmacology; D014527:Uric Acid
D000577:Amides; D000924:Anticholesteremic Agents; D002087:Butyrates; D008055:Lipids; D008074:Lipoproteins; D014527:Uric Acid
AMIDES; ARTHRITIS, RHEUMATOID; ASTHMA; BLOOD LIPIDS; BUTYRATES; CHOLELITHIASIS; CORONARY DISEASE; ENZYME TESTS; FATTY LIVER; HEART BLOCK; HYPERCHOLESTEREMIA; HYPERTENSION; LIPOPROTEINS; LIVER FUNCTION TESTS; OBESITY; PHARMACOLOGY; URIC ACID
CONTRIBUTO CLINICO ALLO STUDIO DI UN NUOVO PRODOTTO ANTICOLESTEROLEMICO DI SINTESI: LA BETA-BENZALBUTIRRAMIDE.